BlackRock Amends INSMED Stake: Passive Investment Update

Ticker: INSM · Form: SC 13G/A · Filed: 2024-01-25T00:00:00.000Z

Sentiment: neutral

Topics: institutional-ownership, passive-investment, amendment, pharmaceuticals

TL;DR

**BlackRock updated its passive stake in INSMED; keep an eye on institutional sentiment.**

AI Summary

BlackRock Inc. filed an amended SC 13G/A on January 25, 2024, indicating a change in its ownership of INSMED Inc. common stock as of December 31, 2023. This amendment, number 11, shows BlackRock's updated passive investment stake in the pharmaceutical company. For investors, this matters because BlackRock is a major institutional investor, and changes in its holdings can signal shifts in market sentiment or investment strategy towards INSMED Inc.

Why It Matters

This filing shows a major institutional investor's updated position in INSMED, which can influence market perception and potentially stock price due to the sheer size of BlackRock's investments.

Risk Assessment

Risk Level: low — This is a routine update from a passive institutional investor and does not indicate any immediate significant risk or opportunity.

Analyst Insight

Investors should note BlackRock's continued passive interest in INSMED Inc. as a sign of ongoing institutional confidence, but this filing alone doesn't warrant immediate action. It's a data point to consider alongside other fundamental and technical analysis.

Key Players & Entities

Forward-Looking Statements

FAQ

What type of filing is this and what does it generally indicate?

This is an SC 13G/A filing, which is an amendment to a Schedule 13G. It generally indicates that a passive institutional investor, like BlackRock Inc., has updated its ownership stake in a company, in this case, INSMED Inc., and that their intent is not to influence or control the company.

Who is the reporting person in this filing?

The reporting person is BlackRock Inc., a major asset management firm with its business address at 50 Hudson Yards, New York, NY.

Which company's securities are being reported on?

The securities being reported on belong to INSMED Inc., a pharmaceutical preparations company located at 700 US Highway 202/206, Bridgewater, NJ.

What was the 'Date of Event Which Requires Filing of this Statement'?

The 'Date of Event Which Requires Filing of this Statement' was December 31, 2023, meaning the reported ownership figures are accurate as of that date.

What is the CUSIP number for the securities mentioned in this filing?

The CUSIP number for the Common Stock of INSMED Inc. mentioned in this filing is 457669307.

From the Filing

EDGAR Filing Documents for 0001086364-24-003815 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home Company Search Current Page Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] SEC Accession No. 0001086364-24-003815 Filing Date 2024-01-25 Accepted 2024-01-25 16:59:33 Documents 1 Document Format Files Seq Description Document Type Size 1 us4576693075_012524.txt SC 13G/A 11793 Complete submission text file 0001086364-24-003815.txt 13661 Mailing Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 Business Address 700 US HIGHWAY 202/206 BRIDGEWATER NJ 08807 908-977-9900 INSMED Inc (Subject) CIK : 0001104506 (see all company filings) EIN. : 541972729 | State of Incorp.: VA | Fiscal Year End: 1231 Type: SC 13G/A | Act: 34 | File No.: 005-59149 | Film No.: 24563034 SIC : 2834 Pharmaceutical Preparations (CF Office: 03 Life Sciences) Mailing Address 50 HUDSON YARDS NEW YORK NY 10001 Business Address 50 HUDSON YARDS NEW YORK NY 10001 212-810-5300 BlackRock Inc. (Filed by) CIK : 0001364742 (see all company filings) EIN. : 320174431 | State of Incorp.: DE | Fiscal Year End: 1231 Type: SC 13G/A SIC : 6211 Security Brokers, Dealers & Flotation Companies (CF Office: 02 Finance)

View on Read The Filing